Personalis Inc Equity-NMS: PSNL


Diagnostics & Research

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$2.73
52W high :$15.28
1Y :-85.87%
5Y :-90.2%
EPS(TTM): :-2.26
Shares O/S :45.97 M
Market cap :131.94 M

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Personalis Inc today?

Personalis Inc (PSNL) share price as of October 11, 2022, is $2.67. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Personalis Inc?

Yes, Indian Investors can invest in the Personalis Inc (PSNL) Share by opening an international trading account with Angel One.

How can I purchase Personalis Inc shares in India?

Purchasing Personalis Inc (PSNL) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Personalis Inc (PSNL) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Personalis Inc?

Yes, you can purchase fractional shares of Personalis Inc (PSNL) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Personalis Inc?

The market capitalization of Personalis Inc on December 3, 2022, is $122.6 M.

In which sector Personalis Inc belongs?

Personalis Inc operates in the Healthcare sector, specifically in the Diagnostics & Research industry.

What documents are required to invest in Personalis Inc stocks?

In order to invest in Personalis Inc (PSNL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Personalis Inc

Personalis, Inc. is a cancer genomics company, which enables precision cancer therapies and diagnostics. The Company is focused on the development of therapies by providing molecular data about each patient's cancer and immune response. It provides sequencing and data analysis services to support the development of cancer therapies. Its NeXT Platform, which provides its biopharmaceutical customers with information on over 20,000 human genes, together with the immune system, in contrast to many cancer panels that cover over 50 to 500 genes. Its NeXT Platform is designed to provide analysis of both a tumor and its immune microenvironment from a single limited tissue sample. Its platform covers the deoxyribonucleic acid sequence of all of the approximately 20,000 human genes. It also reports on transcriptome of a tumor, which encompasses ribonucleic acid expression across human genes, allowing it to determine which of the genomic mutations might actually be driving tumor progression.